Ignite Creation Date:
2024-05-06 @ 2:06 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01968213
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2013-10-17
Brief Title:
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer ARIEL3
Sponsor:
pharmaand GmbH
Organization:
pharmaand GmbH
Organization Data
Organization:
pharmaand GmbH
Class:
INDUSTRY
Study ID:
CO-338-014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
pharmaand GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Myriad Genetics Inc | INDUSTRY |
| Foundation Medicine | INDUSTRY |